Baudax Bio Inc BXRXQ Stock Analysis
- PINK
- Stock
- Market closed · opens Monday 9:30 AM ET
$0.00 unchanged at close Nov 5
Last close · Previous close $0.00
- Market cap
- At the Nov 5 close
- P/E ratio
- On last 12 months’ EPS
- Diluted EPS
- Last 12 months
- Dividend yield
- NoneLast 12 months
Price chart
$0.00unchangedThu, Nov 5 session
Use the left and right arrow keys to move along the chart.
Price data
Trading
- Previous close$0.00Nov 4
- Volume0.00Nov 5 session
Shares traded on all US exchanges in the last completed session. Live intraday volume covers IEX only, so it is left out.
- Avg. volume3.44KLast 21 sessions
The average daily shares traded over the last 21 trading sessions, about one calendar month.
- 52-week range: $0.00 to $0.00; now $0.00
The lowest and highest trades over the past 52 weeks, adjusted for splits. The marker shows the latest price.
Member SIPC.Low CommissionsLearn More (opens in a new tab)Sponsored. Affiliate link: I may earn a commission. The inclusion of Interactive Brokers’ (IBKR) name, logo or weblink is present pursuant to an advertising arrangement only. IBKR is not a contributor, reviewer, provider or sponsor of content published on this site, and is not responsible for the accuracy of any products or services discussed.
Performance
Past performance, measured to the Nov 5 close. Total return includes reinvested dividends.Price change only, without dividends. Compared with the S&P 500, using SPY.
BXRXQ beat the S&P 500 in 2 of 6 periods.
| Period | BXRXQ and S&P 500 | vs S&P 500 |
|---|---|---|
| Short term | ||
| 1M | BXRXQ: unchanged S&P 500: down 5.4% | BXRXQ beat the S&P 500 by 5.4 percentage points Beat |
| 3M | BXRXQ: unchanged S&P 500: down 4.5% | BXRXQ beat the S&P 500 by 4.5 percentage points Beat |
| YTD | BXRXQ: unchanged S&P 500: up 8.3% | BXRXQ trailed the S&P 500 by 8.3 percentage points Trailed |
| 1Y | BXRXQ: unchanged S&P 500: up 9.3% | BXRXQ trailed the S&P 500 by 9.3 percentage points Trailed |
| Long term | ||
| 3Y | BXRXQ: down 100.0% S&P 500: up 74.8% −98.3% vs +20.5% a year | BXRXQ trailed the S&P 500 by 174.8 percentage points Trailed |
| 5Y | BXRXQ: down 100.0% S&P 500: up 67.3% −98.3% vs +10.8% a year | BXRXQ trailed the S&P 500 by 167.3 percentage points Trailed |
$10,000 invested in BXRXQ 5 years ago (Nov 5, 2021) would be worth about $0 at the close on , with dividends reinvested. The same amount in the S&P 500 would be worth about $16,730.
BXRXQ beat the S&P 500 in 2 of 6 periods.
| Period | BXRXQ and S&P 500 | vs S&P 500 |
|---|---|---|
| Short term | ||
| 1M | BXRXQ: unchanged S&P 500: down 5.4% | BXRXQ beat the S&P 500 by 5.4 percentage points Beat |
| 3M | BXRXQ: unchanged S&P 500: down 4.8% | BXRXQ beat the S&P 500 by 4.8 percentage points Beat |
| YTD | BXRXQ: unchanged S&P 500: up 7.5% | BXRXQ trailed the S&P 500 by 7.5 percentage points Trailed |
| 1Y | BXRXQ: unchanged S&P 500: up 8.2% | BXRXQ trailed the S&P 500 by 8.2 percentage points Trailed |
| Long term | ||
| 3Y | BXRXQ: down 100.0% S&P 500: up 68.6% −98.3% vs +19.0% a year | BXRXQ trailed the S&P 500 by 168.6 percentage points Trailed |
| 5Y | BXRXQ: down 100.0% S&P 500: up 56.4% −98.3% vs +9.4% a year | BXRXQ trailed the S&P 500 by 156.4 percentage points Trailed |
$10,000 invested in BXRXQ 5 years ago (Nov 5, 2021) would be worth about $0 at the close on , not counting dividends. The same amount in the S&P 500 would be worth about $15,645.
All-time high
$12,922.00
Closing high on . Now 100.0% below that record.
Split-adjusted daily closes since Nov 22, 2019.
Stock splits
2
Latest: 1-for-40 on . Share counts adjust after each split.
Both splits
- 1-for-40
- 1-for-35
Valuation
Financials
Dividends
Cash dividends per share by ex-dividend year, adjusted for splits.
Dividends per share
Data table
| Year | Per share |
|---|---|
| 2016 | $0.000 |
| 2017 | $0.000 |
| 2018 | $0.000 |
| 2019 | $0.000 |
| 2020 | $0.000 |
| 2021 | $0.000 |
| 2022 | $0.40 |
| 2023 | $0.000 |
| 2024 | $0.000 |
| 2025 | $0.000 |
| 2026 (to date) | $0.000 |
Dividend details
- $0.00Per share, last 12 months
Cash dividends per share with ex-dividend dates in the last 12 months.
- Dividend yield0.00%Last 12 months
- $0.40Ex-dividend
The most recent payment per share. Shares bought on or after the ex-dividend date don’t receive it.
About Baudax Bio Inc
Baudax Bio is a specialty pharmaceutical company focused on therapeutics for acute care settings. The Company’s first commercial product, ANJESO™, had its New Drug Application approved by FDA on February 20, 2020 for the management of moderate to severe pain, alone or in combination with other non-NSAID analgesics. ANJESO is a once daily IV NSAID with preferential Cox-2 activity, which has successfully completed three Phase III clinical trials, including two pivotal efficacy trials, a large double-blind Phase III safety trial and other studies for the management of moderate to severe pain. As a non-opioid, IV meloxicam has the potential to overcome many of the issues associated with commonly prescribed opioid therapeutics, including respiratory depression, constipation, excessive nausea and vomiting, as well as having no addictive potential while maintaining meaningful analgesic effects for relief of pain.
- Sector
- Industry
- Headquarters
- Exchange
- PINK
- Asset type
- Common stock
- Price history since
BXRXQ news
Explore more stocks
Prices are from the last refresh. Open any stock for its live dashboard.
Popular stocks
BXRXQ stock FAQ
What is BXRXQ stock’s price today?
Baudax Bio (BXRXQ) traded at $0.00 at the close on , unchanged from the previous close of $0.00. Over the past 52 weeks it has traded between $0.00 and $0.00.
If you invested $1,000 in BXRXQ 5 years ago, how much would you have now?
With dividends reinvested, $1,000 invested in BXRXQ on would be worth about $0 at the close on , a total return of −100.0%. The same $1,000 would be worth $1,000 if invested one year ago. Past performance doesn’t predict future returns.
Does BXRXQ pay a dividend?
Baudax Bio hasn’t paid a dividend in the last twelve months.
What is BXRXQ’s 52-week high and low?
Over the past 52 weeks BXRXQ has traded as low as $0.00 and as high as $0.00. At $0.00 at the close on , it is 99.0% below that high and 0.0% above the low.
What is BXRXQ’s all-time high?
BXRXQ’s highest closing price was $12,922.00 on , adjusted for stock splits. At $0.00 at the close on , it is 100.0% below that record.
Has BXRXQ stock ever split?
Yes, twice: 1-for-35 on ; 1-for-40 on .
How has BXRXQ stock performed?
Including dividends and measured to the close on , BXRXQ has returned 0.0% so far this year and 0.0% over the past year, and −100.0% over five years (−98.3% a year). Over the same periods the S&P 500, measured by SPY, returned +8.3%, +9.3% and +67.3%. Past performance doesn’t predict future returns.
What exchange does BXRXQ trade on?
Baudax Bio trades on the PINK under the ticker symbol BXRXQ. Its price history on this dashboard begins on .
Member SIPC.Low CommissionsLearn More (opens in a new tab)Sponsored. Affiliate link: I may earn a commission. The inclusion of Interactive Brokers’ (IBKR) name, logo or weblink is present pursuant to an advertising arrangement only. IBKR is not a contributor, reviewer, provider or sponsor of content published on this site, and is not responsible for the accuracy of any products or services discussed.
About this data. Data sourced by Tiingo (opens in a new tab). The live price is Tiingo’s real-time price, based on IEX trades and quotes; intraday charts show IEX trades, and volume figures are consolidated totals for completed sessions. Prices are split-adjusted, and total returns assume dividends are reinvested. Financials come from company filings and can lag new reports. Times are Eastern.
This page is for education, not investment advice. Past performance doesn't predict future returns. Logos provided by Logo.dev (opens in a new tab).
The Interactive Brokers word and logo are trademarks of Interactive Brokers LLC (or its subsidiaries) in the US and/or elsewhere. All rights reserved.